Effect of smoking on tuberculosis treatment outcomes: A systematic review and meta-analysis

Abstract

IntroductionNumerous studies have explored an effect of cigarette smoking on tuberculosis treatment outcomes but with dissimilar conclusions. ObjectiveTo determine the effect of cigarette smoking on tuberculosis treatment outcomes. MethodsPubMed, Cochrane library and Google scholar databases were searched last on February 27, 2019. We applied the random-effects model for the analysis. Publication bias was assessed using funnel plot and Egger's regression. Furthermore, we performed Orwin's Fail-Safe N and cumulative meta-analysis to check for small studies' effect. ResultsOut of 22 studies we included in the qualitative synthesis, 12 studies reported p-values less than 0.05 where smoking significantly favored poor treatment outcomes. The remaining 10 studies reported p-values larger than 0.05 implying that smoking does not affect the treatment outcomes. Twenty studies met the criteria for inclusion in a meta-analysis. The metaanalysis found that smoking significantly increased the likelihood of poor tuberculosis treatment outcomes by 51% (OR = 1.51; 95% CI = 1.30 to 1.75 and I-square = 75.1%). In a subgroup analysis, the effect was higher for low-and middle-income countries (OR = 1.74; 95% CI = 1.31 to 2.30) and upper-middle-income economies (OR = 1.52; 95% CI = 1.16 to 1.98) than for high-income ones (OR = 1.34; 95% CI = 1.03 to 1.75) even though the differences in the effects among the strata were not statistically significant as demonstrated by overlapping of confidence intervals of the effects. Meta-regression analysis, adjusted for income PLOS ONE |

The Blood Neutrophil Count After 1 Month of Treatment Predicts the Radiologic Severity of Lung Disease at Treatment End

“…There is some evidence that delayed presentation or treatment initiation correlates with poorer resolution of chest x-ray abnormalities [2,10,11] although not all studies confirm this [12]. Smoking has also been related to poor treatment outcomes in tuberculosis [13]. The burden of infection (as assessed by sputum smear grade, for example) has been demonstrated to correlate with baseline radiological severity [14] but it is less clear how this relates to abnormalities at the end of treatment.…”

Prevalence of cardiovascular risk factors in active tuberculosis in Africa: a systematic review and meta-analysis

“…Moreover, smoking interacts with DM to synergistically increase the risk for TB 67 . The high prevalence of smoking and DM in active TB is concerning because both increase the risk of adverse TB treatment outcomes 14,68 . It was interesting to observe similar prevalence of DM in DRTB even when the criteria for the diagnosis of DM in DRTB was unknown in four of the five studies included in the sub-analysis for DM 35,36,39,57 .…”

“…Moreover, CVD accounts for 20% of deaths among survivors of TB after TB treatment completion 13 . On the one hand, CVR factors such as smoking 14,15 , alcohol use 16,17 and diabetes mellitus (DM) 18,19 are risk factors for TB infection and poor TB outcomes. On the other hand, obesity is protective against TB infection and adverse outcomes 20,21 .…”

CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance

“…Symptoms include a chronic cough with blood-tinged mucus, weight loss, fever, and night sweats. Smoking and an HIV/AIDS infection could make tuberculosis worse [154]. With nearly 10 million active infections and 1.5 million deaths estimated in 2020, the disease only trailed COVID-19 as the largest cause of infection-related deaths [155].…”